Riskpilot← Back to searchSign inGet full accessNatumin Pharma AB
ABActiveOrg 5564747748Snickaregatan 10Manufacture of perfume and toilet preparations · NACE 2042Est. 199324 employees
Revenue 2024
SEK 67,1M
-1% vs 2023
EBITDA margin
-4.9%
-345% vs 2023
Equity ratio
21.9%
Financial strength
Net profit 2024
SEK -870K
-113% vs 2023
| Revenue | SEK 67,1M | -1% |
| EBITDA | SEK -3,3M | -345% |
| Net profit | SEK -870K | -113% |
| Total assets | SEK 116,4M | +90% |
| Equity | SEK 25,5M | -3% |
| Employees | 24 | — |
Legal name
Natumin Pharma AB
Org number
5564747748
Legal form
Aktiebolag
NACE code
2042 · Manufacture of perfume and toilet preparations
Founded
21 oktober 1993
Share capital
SEK 2 000 000
Employees
24 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva produktion av- och handel med medicintekniska produkter, kosmetika, kosttillskott och dryck samt därmed förenlig verksamhet. Bolaget skall även bedriva produktutveckling inom sina verksamhetsområden.
Address
Snickaregatan 10
Phone
+4636396550
Email
info@natumin.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 64 267 | 54 404 | 59 233 | 62 169 | 65 733 | 67 728 | 67 056 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −6 006 | −821 | −3 318 | 7 986 | −5 301 | −8 091 | −6 144 | −2 600 | −743 | −3 310 |
| Depreciation & amort. | — | −1 551 | −1 677 | −1 763 | −1 768 | −1 682 | −1 511 | −884 | −610 | −681 |
| EBIT | −6 006 | −2 372 | −4 995 | 6 223 | −7 069 | −9 773 | −7 655 | −3 484 | −1 353 | −3 991 |
| Net financials | −237 | −426 | −362 | −348 | −298 | −236 | −383 | −513 | 3 319 | −1 178 |
| Profit before tax | −5 348 | 4 305 | 1 588 | 14 896 | −1 920 | −2 990 | −3 306 | −3 997 | 6 788 | −869 |
| Tax | −0 | −0 | −0 | −3 192 | −24 | −0 | −0 | −0 | −0 | −1 |
| Net profit | −5 348 | 4 305 | 1 588 | 11 704 | −1 944 | −2 990 | −3 306 | −3 997 | 6 788 | −870 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 35 104 | 45 114 | 50 254 | 62 830 | 63 553 | 44 749 | 51 392 | 54 904 | 61 324 | 116 406 |
| Equity | 4 454 | 18 458 | 20 099 | 31 803 | 29 859 | 26 869 | 23 563 | 19 566 | 26 354 | 25 484 |
| Long-term debt | 11 454 | 7 983 | 8 728 | 1 950 | 4 650 | 10 337 | 7 146 | 12 111 | 16 168 | 72 318 |
| Short-term debt | 17 308 | 17 448 | 12 097 | 16 295 | 17 202 | 7 543 | 20 683 | 23 228 | 18 802 | 18 604 |
| Total debt | 28 762 | 25 431 | 20 825 | 18 245 | 21 852 | 17 880 | 27 829 | 35 339 | 34 970 | 90 922 |
EBITDA margin
-4.9%
This company
15.8%
Market median
-131% vs market
20152024
Equity ratio
21.9%
This company
38.2%
Market median
-43% vs market
20152024
Return on equity
-3.4%
This company
18.4%
Market median
-118% vs market
20152024
Net profit margin
-1.3%
This company
8.1%
Market median
-116% vs market
20152024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20152024
Debt / equity
3.57×
This company
0.62×
Market median
-476% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SK External Signatory | External Signatory | 2021 | — | — |
BM Chief Auditor | Chief Auditor | 2020 | — | — |
SR Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
SC Chief Auditor | Chief Auditor | 2022 | — | — |
BC Chief Auditor | Chief Auditor | 2023 | — | — |
PM External Signatory | External Signatory | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nya MedicaNatumin AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Humble Group AB
Natumin Pharma AB Board members of Natumin Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Kristina Wulff | External Signatory | 0 companies |
| Bo Magnus Lagerberg | Chief Auditor | 0 companies |
| Stig Rikard Westrin | Chief Executive Officer | 0 companies |
| Sandra Clara Ellen Hvitman | Chief Auditor | 0 companies |
| Bengt Claes Joakim Falck | Chief Auditor | 0 companies |
| Paul Martin Kreutz | External Signatory | 0 companies |
| Kjell Lundgren | Deputy Board Member | 0 companies |
| Emil Mikael Svahn | Board of Directors | 0 companies |
| Noel Christofer Peter Abdayem | Board of Directors | 0 companies |
| Simon Gustav Seved Petrén | Chairman | 0 companies |
| Marcus Erik Johan Stenkil | Chairman | 0 companies |
| Johan Christer Lennartsson | Board of Directors | 0 companies |
| Ulrika Ann-Britt Albers | Chairman | 0 companies |
| Bengt Peter Carlsson | Board of Directors | 0 companies |
| Jan Peter Hencz | Chairman | 0 companies |